BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30897334)

  • 21. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
    Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
    PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
    Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
    Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
    Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR‑455‑5p promotes cell invasion and migration in breast cancer.
    Aili T; Paizula X; Ayoufu A
    Mol Med Rep; 2018 Jan; 17(1):1825-1832. PubMed ID: 29257232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of TAFI by siRNA inhibits invasion and migration of breast cancer cells.
    Yu C; Luan Y; Wang Z; Zhao J; Xu C
    Mol Med Rep; 2017 Sep; 16(3):3469-3474. PubMed ID: 28765963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
    Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
    Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
    Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
    Wang S; Li H; Wang J; Wang D; Yao A; Li Q
    Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
    Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
    Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
    Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Liu X; Bi L; Wang Q; Wen M; Li C; Ren Y; Jiao Q; Mao JH; Wang C; Wei G; Wang Y
    Oncogene; 2018 Jun; 37(25):3426-3439. PubMed ID: 29555976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
    Ni J; Peng Y; Yang FL; Xi X; Huang XW; He C
    Onco Targets Ther; 2018; 11():3303-3312. PubMed ID: 29892197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic values of F-box members in breast cancer: an online database analysis and literature review.
    Wang X; Zhang T; Zhang S; Shan J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30341246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.